[ Price : $8.95]
FDA says Hikma Pharmaceuticals has sufficiently corrected GMP violations at its Portuguese drug manufacturing facility.[ Price : $8.95]
Gilead says its Phase 3 study of Zydelig combined with bendamustine and rituximab for treating patients with relapsed chronic lymp...[ Price : $8.95]
FDA says it is requiring manufacturers of iodinated contrast media to study the potential for infants to develop underactive thyro...[ Price : $8.95]
FDA continues its crackdown against laboratory-developed test makers, sending a letter to HarmonyX about its tests for antiplatele...[ Price : $8.95]
U.S. presidential hopeful Bernie Sanders (I-VT) grills FDA commissioner-nominee Robert Califf about his relationship with the drug...[ Price : $8.95]
Several federal agencies announce coordinated enforcement efforts against a number of dietary supplement manufacturers.[ Price : $8.95]
In its latest batch of Warning Letters FDA cites Heritage Pharmaceuticals and Life Support Development.[ Price : $8.95]
FDAs New Jersey District Office warns Heritage Pharmaceuticals about violations of Postmarketing Adverse Drug Event Reporting requ...